Sfoglia per Autore
Design, synthesis and biological evaluation of novel antitubercular agents targeting the Salycilate Syntase (MbtI).
2018 S. Villa, L.R. Chiarelli, M. Mori, D. Barlocco, A. Gelain, E. Pini, G. Mori, L. Costantino, T. Tuccinardi, F. Meneghetti
Structure-based drug design, synthesis and biological assays of P. falciparum Atg3-Atg8 protein-protein interaction inhibitors
2018 S. Villa, L. Legnani, D. Colombo, A. Gelain, C. Lammi, D. Bongiorno, D.P. Ilboudo, K.E. Mcgee, J. Bosch, G. Grazioso
New Chromane-Based Derivatives as Inhibitors of Mycobacterium tuberculosis Salicylate Synthase (MbtI) : Preliminary Biological Evaluation and Molecular Modeling Studies
2018 E. Pini, G. Poli, T. Tuccinardi, L. Chiarelli, M. Mori, A. Gelain, L. Costantino, S. Villa, F. Meneghetti, D. Barlocco
Discovery and development of novel salicylate synthase (MbtI) Furanic inhibitors as antitubercular agents
2018 L.R. Chiarelli, M. Mori, D. Barlocco, G. Beretta, A. Gelain, E. Pini, M. Porcino, G. Mori, G. Stelitano, L. Costantino, M. Lapillo, D. Bonanni, G. Poli, T. Tuccinardi, S. Villa, F. Meneghetti
A click chemistry approach to explore a new scaffold for potential antitubercular agents
2018 M. Mori, S. Villa, A. Gelain, L.R. Chiarelli, F. Meneghetti
Signal Transducer and Activator of Transcription Protein 3 (STAT3) : an Update on its Direct Inhibitors as Promising Anticancer Agents
2019 A. Gelain, M. Mori, F. Meneghetti, S. Villa
Exploring the biological activity of a library of 1,2,5-oxadiazole derivatives endowed with antiproliferative activity
2019 A. Gelain, M. Mori, F. Meneghetti, F. Porta, L. Basile, G. Marverti, A. Asai, M. Hyeraci, A.N. García-Argáez, L.D. Via, S. Guccione, S. Villa
Multi-target antitubercular drugs: identification of novel dual MbtI and MptpB inhibitors
2019 M. Mori, S. Villa, L.R. Chiarelli, G. Stelitano, A. Gelain, T. Tuccinardi, M. Bellinzoni, F. Meneghetti
5,6-Dimethyl-1,3-dihydrobenzo[c][1,2,5]thiadiazole-2,2-dioxide as new STAT3 inhibitor
2019 S. Villa, M. Mori, F. Meneghetti, A. Pedretti, L. Regazzoni, D. Colombo, A. Asai, A. Gelain
Unravelling the Antiproliferative Activity of 1,2,5-oxadiazole Derivatives
2019 D. Ehrsam, F. Porta, M. Mori, H.E.M.Z. Schwabedissen, L. Dalla Via, A.N. Garcia-Argaez, L. Basile, F. Meneghetti, S. Villa, A. Gelain
Exploring the role of the heterocyclic moiety of 5-(4-nitrophenyl)-2-furoic acid, a promising inhibitor of MBTI from mycobacterium tuberculosis
2019 M. Mori, L. Chiarelli, G. Stelitano, A. Gelain, T. Tuccinardi, M. Bellinzoni, F. Meneghetti, S. Villa
Structural insights for the development of novel antituberculars targeting the iron uptake pathway
2019 M. Mori, S. Villa, L.R. Chiarelli, G. Stelitano, A. Gelain, T. Tuccinardi, M. Bellinzoni, F. Meneghetti
Discovery of Novel Naphthylphenylketone and Naphthylphenylamine Derivatives as Cell Division Cycle 25B (CDC25B) Phosphatase Inhibitors : Design, Synthesis, Inhibition Mechanism and in Vitro Efficacy against Melanoma Cell Lines
2019 C. Cerchia, R. Nasso, M. Mori, S. Villa, A. Gelain, A. Capasso, F. Aliotta, M. Simonetti, R. Rullo, M. Masullo, E. De Vendittis, M.R. Ruocco, A. Lavecchia
An Overview on the Potential Antimycobacterial Agents Targeting Serine/Threonine Protein Kinases from Mycobacterium tuberculosis
2019 M. Mori, J.C. Sammartino, L. Costantino, A. Gelain, F. Meneghetti, S. Villa, L.R. Chiarelli
Unravelling the interactions between an antiproliferative 1,2,5-oxadiazole derivative and STAT3
2019 A. Gelain, M. Mori, F. Meneghetti, A. Asai, S. Villa
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents
2019 L.R. Chiarelli, M. Mori, G. Beretta, A. Gelain, E. Pini, J.C. Sammartino, G. Stelitano, D. Barlocco, L. Costantino, M. Lapillo, G. Poli, I. Caligiuri, F. Rizzolio, M. Bellinzoni, T. Tuccinardi, S. Villa, F. Meneghetti
Structural and biochemical investigations into the binding mode of furan-based inhibitors of MbtI from M. tuberculosis
2020 M. Mori, S. Villa, L.R. Chiarelli, G. Stelitano, A. Gelain, T. Tuccinardi, M. Bellinzoni, F. Meneghetti
6-Hydroxy-2-methylbenzofuran-4-carboxylic acid
2020 M. Mori, F. Meneghetti, L.R. Chiarelli, A. Diego, D. Nava, A. Gelain, G. Cazzaniga, S. Villa, E.R.E. Pini
Shedding X-ray light on the role of magnesium in the activity of M. tuberculosis salicylate synthase (MbtI) for drug design
2020 M. Mori, G. Stelitano, A. Gelain, E. Pini, L.R. Chiarelli, J.C. Sammartino, G. Poli, T. Tuccinardi, G. Beretta, A. Porta, M. Bellinzoni, S. Villa, F. Meneghetti
A dual-target approach in anti-tuberculosis therapy: new MptpB/MbtI inhibitors
2020 G. Cazzaniga, M. Mori, A. Gelain, E. Pini, G. Stelitano, L.R. Chiarelli, F. Meneghetti, S. Villa
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile